Nuvation Bio Inc (NUVB) stock is currently valued at $2.69. During the last session, the stock experienced a remarkable rise, reaching $10.0 after opening at $2.69. The stock briefly dropped to $6.0 before ultimately closing at $2.9.
The market performance of Nuvation Bio Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $3.45 on 01/07/25, while the lowest value for the same duration was $1.54 on 04/07/25.
52-week price history of NUVB Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Nuvation Bio Inc’s current trading price is -22.14% away from its 52-week high, while its distance from the 52-week low is 74.68%. The stock’s price range during the 52-week period has remained between $1.54 and $3.45. In the Healthcare sector, the company’s shares saw a trading volume of around 4.69 million for the day, which was evidently lower than the average daily volume of 6.32 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Nuvation Bio Inc (NUVB) has experienced a quarterly rise of 16.96% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 923.40M and boasts a workforce of 220 employees.
A Closer Look at Analysts’ Ratings for Nuvation Bio Inc
As of right now, 4 analysts are rating Nuvation Bio Inc as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.17, with a change in price of +0.81. Similarly, Nuvation Bio Inc recorded 5,177,326 in trading volume during the last 100 days, posting a change of +43.09%.
Examining NUVB’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for NUVB stands at 0.55. Similarly, the long-term debt-to-equity ratio is also 0.52.
NUVB Stock Stochastic Average
As of today, Nuvation Bio Inc’s raw stochastic average for the last 50 days stands at 82.96%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 68.92%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 83.14% and 87.29%, respectively.
NUVB Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -2.18%. However, over the last six months, the performance has been weaker by 15.95%. The price of NUVB increased 14.47% over the last 30 days. And in the last five days, it has surged by 15.95%.
